Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.68
(
-1.35%
)
Bitcoin
75,759.72
(
-0.11%
)
News Focus
News Focus
Post# of 8193
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Camaro1093

Send PM Follow Ignore
Followers 14
Posts 1226
Boards Moderated 1
Alias Born 08/16/2009

Camaro1093

Re: General Grievous post# 80

Tuesday, 12/29/2009 7:45:43 AM

Tuesday, December 29, 2009 7:45:43 AM

Post# of 8193
You're right, we have 117M shares outstanding.

From the BioMedReports interview w/ the CEO: "We're trading at around a dollar, we have 117 million shares outstanding (40 million in the float) between common and preferred, which puts us at about $100 million market cap."

http://biomedreports.com/articles/most-popular/22199-novelos-eyeing-qrevolutionaryq-phase-iii-cancer-study-results.html

GLTA.

Visit my biotech investing board!: investorshub.advfn.com/boards/board.aspx?board_id=16653



GLTA.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CLRB News
More CLRB News